Literature DB >> 2205653

An immunogenic 30-kDa surface antigen of pathogenic clinical isolates of Entamoeba histolytica.

P Blakely1, P G Sargeaunt, S L Reed.   

Abstract

A 30-kDa surface antigen was identified by Western blots with human immune sera in all 15 isolates of E. histolytica from patients with invasive amebiasis (pathogenic) but not in 15 strains from asymptomatic patients (nonpathogenic). This antigen is highly immunogenic in naturally infected humans and was recognized by sera from 22 patients with invasive disease but not by sera from 13 patients harboring nonpathogenic strains. Its surface location is supported by its differential extraction in the detergent phase of Triton X-114 and by surface immunofluorescence of live trophozoites. Unlike previously described amebic surface antigens, this 30-kDa antigen is undetectable in axenic strains that were originally isolated from patients with invasive disease but have been adapted to grow without bacteria. Affinity-purified antibody to the 30-kDa antigen did not promote lysis of complement-resistant pathogenic strains. This surface antigen may be diagnostically important in the identification of pathogenic clinical isolates.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2205653     DOI: 10.1093/infdis/162.4.949

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  10 in total

1.  The invasiveness of Entamoeba histolytica - a continuing enigma.

Authors:  J P Ackers
Journal:  Clin Mol Pathol       Date:  1996-08

2.  Nucleotide sequence of a small subunit ribosomal RNA (16S-like rRNA) gene from Entamoeba histolytica: differentiation of pathogenic from nonpathogenic isolates.

Authors:  X Que; S L Reed
Journal:  Nucleic Acids Res       Date:  1991-10-11       Impact factor: 16.971

3.  Modulation of a surface antigen of Entamoeba histolytica in response to bacteria.

Authors:  A Bhattacharya; R Ghildyal; J Prasad; S Bhattacharya; L S Diamond
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

4.  Inhibition of the complement membrane attack complex by the galactose-specific adhesion of Entamoeba histolytica.

Authors:  L L Braga; H Ninomiya; J J McCoy; S Eacker; T Wiedmer; C Pham; S Wood; P J Sims; W A Petri
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

5.  Cell surface proteins of Entamoeba histolytica.

Authors:  B J Mann; W A Petri
Journal:  Parasitol Today       Date:  1991-07

6.  A monoclonal antibody for distinction of invasive and noninvasive clinical isolates of Entamoeba histolytica.

Authors:  A Gonzalez-Ruiz; R Haque; T Rehman; A Aguirre; C Jaramillo; G Castañon; A Hall; F Guhl; G Ruiz-Palacios; D C Warhurst
Journal:  J Clin Microbiol       Date:  1992-11       Impact factor: 5.948

Review 7.  Amebiasis.

Authors:  D A Bruckner
Journal:  Clin Microbiol Rev       Date:  1992-10       Impact factor: 26.132

8.  Molecular and cellular characterization of the 29-kilodalton peripheral membrane protein of Entamoeba histolytica: differentiation between pathogenic and nonpathogenic isolates.

Authors:  S L Reed; B M Flores; M A Batzer; M A Stein; V L Stroeher; J E Carlton; D L Diedrich; B E Torian
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

9.  Biochemical and immunological studies on soluble antigens of Entamoeba histolytica.

Authors:  P Das; K Sengupta; S Pal; D Das; S C Pal
Journal:  Parasitol Res       Date:  1993       Impact factor: 2.289

10.  Genetic differentiation of pathogenic and nonpathogenic strains of Entamoeba histolytica by random amplified polymorphic DNA polymerase chain reaction.

Authors:  U Mackenstedt; A M Johnson
Journal:  Parasitol Res       Date:  1995       Impact factor: 2.289

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.